A Personalized Approach to Parkinson's disease patients based on founder mutation analysis
While the phenotype of Parkinson disease (PD) is heterogeneous, treatment approaches are mostly uniform. Personalized medicine aims to treat diseases with targeted therapies based on cumulative variables including genotype. We believe that sufficient evidence has accumulated to warrant the initiatio...
Main Authors: | Nir eGiladi, Anat eMirelman, Avner eThaler, Avi eOrr-Urtreger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2016.00071/full |
Similar Items
-
<i>MAPT</i> Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified Analysis
by: Shachar Shani, et al.
Published: (2023-12-01) -
R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies
by: Orly Goldstein, et al.
Published: (2021-01-01) -
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
by: Laura J. Smith, et al.
Published: (2022-08-01) -
Editorial: Genotype-Phenotype Correlation in Parkinsonian Conditions
by: Luca Marsili, et al.
Published: (2021-08-01) -
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
by: Yuting Tang, et al.
Published: (2023-06-01)